RTW Biotech Opportunities Ltd
RTWFF
$1.20
$0.010.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 96.37% | 77.33% | 53.67% | 68.88% | 92.42% |
| Total Revenue | 96.37% | 77.33% | 53.67% | 68.88% | 92.42% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 96.37% | 77.33% | 53.67% | 68.88% | 92.42% |
| SG&A Expenses | 69.16% | 50.34% | 31.13% | 22.35% | 12.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.82% | 50.81% | 31.30% | 19.53% | 7.23% |
| Operating Income | -32.77% | -20.61% | -10.56% | 14.00% | 33.70% |
| Income Before Tax | -58.91% | -5.22% | 40.87% | 282.24% | 310.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.91% | -5.22% | 40.87% | 282.24% | 310.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.91% | -5.22% | 40.87% | 282.24% | 310.95% |
| EBIT | -32.77% | -20.61% | -10.56% | 14.00% | 33.70% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -74.15% | -29.64% | 8.76% | 228.73% | 312.18% |
| Normalized Basic EPS | 258.82% | 302.76% | 368.13% | 190.95% | -376.00% |
| EPS Diluted | -74.15% | -29.64% | 8.76% | 228.73% | 312.18% |
| Normalized Diluted EPS | 258.82% | 302.76% | 368.13% | 190.95% | -376.00% |
| Average Basic Shares Outstanding | 58.72% | 43.64% | 28.62% | 14.10% | -0.41% |
| Average Diluted Shares Outstanding | 58.72% | 43.64% | 28.62% | 14.10% | -0.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |